Benzinga's Top Upgrades

Analysts at Goldman Sachs upgraded

from Neutral to Buy. The price target for Clovis Oncology has been raised from $60 to $66. Clovis Oncology shares closed at $77.40 on Friday. Deutsche Bank upgraded

from Hold to Buy. Diana Shipping shares closed at $6.09 on Friday. Analysts at Credit Suisse upgraded

from Underperform to Neutral. The price target for St Jude Medical is set to $74. St Jude Medical shares closed at $68.17 on Friday. Analysts at UBS upgraded

from Neutral to Buy. The price target for Netflix has been raised from $370 to $565. Netflix shares closed at $454.57 on Friday. BMO Capital upgraded

from Market Perform to Outperform. The price target for AbbVie has been raised from $60 to $68. AbbVie shares closed at $61.49 on Friday. Analysts at Jefferies upgraded

from Hold to Buy. UnitedHealth shares closed at $119.00 on Friday. Citigroup upgraded

from Neutral to Buy. The price target for Freeport-McMoRan has been raised from $19 to $23. Freeport-McMoRan shares closed at $18.25 on Friday. Analysts at Piper Jaffray upgraded

from Neutral to Overweight. The price target for Christopher & Banks has been raised from $5 to $10. Christopher & Banks shares closed at $5.63 on Friday. Bank of America upgraded

from Neutral to Buy. The price target for Marathon Oil has been raised to $36. Marathon Oil shares closed at $29.18 on Friday. Analysts at KeyBanc upgraded

from Sector Weight to Overweight. The price target for IPC Healthcare is set to $56. IPC Healthcare shares closed at $48.65 on Friday. Baird upgraded

from Neutral to Outperform. The price target for The Habit Restaurants is set to $41. The Habit Restaurants shares closed at $31.00 on Friday.